Crescent Biopharma
CBIO· Manufacturing· Fiscal year ends in December
No proxy on file names the CEO of Crescent Biopharma.
Executives3
See all- 1EllNot disclosed
- 2Jonathan McNeillNot disclosed
- 3JoshNot disclosed
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Peers
No disclosed peer group
No proxy on file names a pay peer group for Crescent Biopharma. The peer group comes from the proxy statement, so it shows here when a proxy read has it.
Board2
See all- Timothy PearsonChair · 9 yr on the boardIndependentCompensation (Chair)—Paid as an executive
- Daniel JuniusDirector · 7 yr on the boardIndependentAudit (Chair)—Paid as an executive
The board of the latest proxy (FY2023).
Shared directors
Activity
Filings5
See all| Proxy statement | DEF 14A | Apr 21, 2026 | FY2025 |
| Annual report | 10-K | Feb 26, 2026 | FY2025 |
| Annual report | 10-K | Feb 13, 2025 | FY2024 |
| Proxy statement | DEF 14A | Apr 1, 2024 | FY2023 |
| Annual report | 10-K | Mar 27, 2024 | FY2023 |
